Nimesulida Neuride (Nimesulide)

Nimesulide, the active ingredient in Nimesulida Neuride, is a non‑steroidal anti‑inflammatory drug (NSAID) presented as an oral dosage form for oral use. It is used to relieve mild to moderate pain, reduce inflammation in conditions such as osteoarthritis, and treat dysmenorrhea.

GNH USA supplies Nimesulida Neuride as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand. Customers benefit from reliable logistics, documentation support, and responsive technical assistance throughout the procurement process.

Nimesulide is indicated for several pain‑related and inflammatory conditions, acting through COX‑2 inhibition to reduce prostaglandin‑mediated symptoms.

- Mild to moderate pain: provides analgesic relief for acute or chronic pain such as headache or musculoskeletal discomfort. - Osteoarthritis: reduces joint inflammation and improves mobility in patients with degenerative joint disease. - Dysmenorrhea: alleviates menstrual cramps by decreasing uterine prostaglandin production.

Nimesulide may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia or abdominal pain. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Skin rash or mild itching. - Elevated liver enzymes detected in routine tests.

Serious or Rare Side Effects: - Hepatotoxicity: severe liver injury or hepatitis. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Renal impairment: acute kidney injury or worsening chronic kidney disease. - Cardiovascular events: increased risk of thrombotic events or hypertension. - Anaphylaxis: life‑threatening allergic reaction.

When prescribing Nimesulide, clinicians should consider several precautionary measures to minimize risk. - Assess liver function: avoid use in patients with active hepatic disease or elevated transaminases. - Evaluate renal status: use cautiously in those with impaired kidney function. - Monitor gastrointestinal risk: patients with a history of ulcers or bleeding should be closely observed. - Review cardiovascular history: avoid in individuals with uncontrolled hypertension or recent thrombotic events. - Check concomitant medications: avoid combining with other COX‑2 inhibitors or hepatotoxic drugs. - Store at ambient temperature: keep below 25 °C in the original packaging, protected from moisture and direct sunlight.

Nimesulide can interact with other medicines, affecting its safety or efficacy.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs or COX‑2 inhibitors: additive gastrointestinal toxicity. - Hepatotoxic agents (e.g., isoniazid, methotrexate): heightened liver injury risk. - Lithium: reduced renal clearance leading to toxicity. - ACE inhibitors or diuretics: may diminish antihypertensive effect and impair renal function.

Moderate Interactions (Monitor Closely): - SSRIs or SNRIs: modest increase in bleeding tendency. - Corticosteroids: enhanced risk of gastrointestinal ulceration. - Cyclosporine: possible increase in nephrotoxicity. - Oral hypoglycemics: may affect blood glucose control. - Antiretrovirals (e.g., protease inhibitors): potential alteration of drug metabolism.